Navigation Links
Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
Date:8/27/2008

Parents of students with known allergies are urged to put auto-injectable

epinephrine at the top of the school supplies list

SILVER SPRING, Md., Aug. 27 /PRNewswire/ -- A new survey conducted by the National Association of School Nurses (NASN) found that 72% of school nurses have students with a known history of allergies or prior use of epinephrine whose parents have not provided the school with auto-injectable epinephrine. Also known as adrenaline, epinephrine is the first-line standard of care for treating anaphylaxis. Anaphylaxis is a severe allergic reaction that can be caused by nuts, insect bites or stings and other allergens.(1,2,3) Eight out of ten school nurses (82%) surveyed have also seen increased numbers of children at risk for anaphylaxis in the past few years.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/NASNbacktoschoolsurvey/34387/

"We cannot overlook the importance of preparation when sending students back to school," said Amy Garcia, RN, MSN, executive director of NASN. "It is crucial that parents of children at risk for severe allergic reactions provide the school with auto-injectable epinephrine."

As many as 45 million Americans have allergic sensitivities that put them at risk for anaphylaxis.(4) It takes only one to two minutes for a mild allergic reaction to escalate to anaphylaxis.(5) The faster the onset of an anaphylactic reaction, the greater the likelihood that it will be severe.(6) Most anaphylactic deaths have occurred when auto-injectable epinephrine was not used or not used in time.(7,8,9)

The online survey of 489 school nurses also found that:

-- 56% have witnessed anaphylaxis at school

-- 68% support or strongly support making stock auto-injectable

epinephrine universally available in schools

-- 72% said that establishing a policy by the local school district would

strengthen support for creating a stock auto-injectable epinephrine

program in their school(s)

-- 93% have students with prescribed auto-injectable epinephrine for whom

the school stores the medication

Larry S. Posner, MD, FAAAAI, assistant clinical professor at UC San Francisco said, "Being prepared in case of an emergency is critical in preventing the most serious effects, since accidental exposure to known food allergens are the rule rather than the exception and anaphylaxis may progress very quickly. We know that in fatal anaphylaxis, respiratory or cardiac arrest will usually occur within 10-20 minutes for bee stings and within 20-45 minutes for food reactions.(10) That gives very little time for an appropriate response."

Due to the quick onset of anaphylaxis, being prepared is vital to keeping children safe. "Creating a plan to prevent exposures and respond to severe allergic reactions in our schools requires informing classmates, teachers and other school staff about the student's allergy and teaching them to recognize the symptoms so they can assist if an emergency arises. It also means having auto-injectable epinephrine handy that is easy to use and can be quickly administered in a crisis situation," Ms. Garcia said.

About the NASN Survey

NASN's "Management of Asthma and Anaphylaxis in Schools Survey" was an anonymous online survey conducted between May 17 and July 11, 2008 among U.S. school nurses. 489 nurses completed the 80-question survey, which included multiple choice questions and free-form responses.

The survey was adapted from a survey conducted with the California School Nurse Organization (CSNO) and West Coast Allergy and Asthma Network (WestCAAN). Dr. Larry Posner and Nancy Spradling, executive director of the CSNO developed the CSNO/WestCAAN survey.

About NASN

The National Association of School Nurses is a non-profit specialty nursing organization, incorporated in 1977, which represents school nurses exclusively. NASN has over 13,000 members and 51 affiliates, including the District of Columbia and overseas. The mission of the NASN is "to advance the delivery of professional school health services to promote optimal health and learning in students." To learn more about NASN, please visit us on the web at http://www.nasn.org or call 866-627-6767. For state specific information, please select "Affiliate Organizations" under "QUICKLINKS" on the NASN homepage.

References:

(1) Boudreau-Romano et al. A Retrospective Review Of Anaphylaxis

Management In A Pediatric Emergency Department. J Allergy Clin

Immunol. 2008; (121:2): S25

(2) Jarvinen et al. Use Of Epinephrine In Food-induced Anaphylaxis In

Children. J Allergy Clin Immunol. 2007; (119:1): S29

(3) Gold and Sainbury. First aid anaphylaxis management in children who

were prescribed an epinephrine autoinjector device (EpiPen). J

Allergy Clin Immunol. 2000; (106:1): 171-176

(4) Neugut AI et al. Anaphylaxis in the United States. Arch Int Med.

2001;161:15-21.

(5) The Merck Manual. Merck Research Laboratories. 2006-2008.

(6) Nicklas et al. Anaphylaxis. Supplement to: J Allergy Clin Immunol.

1998;101(6:2):498S-501S;S469

(7) Boudreau-Romano et al. A Retrospective Review Of Anaphylaxis

Management In A Pediatric Emergency Department. J Allergy Clin

Immunol. 2008; (121:2): S25

(8) Jarvinen et al. Use Of Epinephrine In Food-induced Anaphylaxis In

Children. J Allergy Clin Immunol. 2007; (119:1): S29

(9) Gold and Sainbury. First aid anaphylaxis management in children who

were prescribed an epinephrine autoinjector device (EpiPen). J

Allergy Clin Immunol. 2000; (106:1): 171-176

(10) Pumphrey RSH. J Allergy Clin Immunol. 2003;112(2):451


'/>"/>
SOURCE National Association of School Nurses (NASN)
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
2. Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder
3. Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech
4. Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia
5. Video: Data From 185,000 ICU Admissions Show Significant Reductions in Mortality:
6. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
7. Video: Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck
8. Half of Surveyed Physicians Expect to Replace Between 6 Percent and 15 Percent of Their Sustiva Prescriptions with Isentress
9. Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science
10. AstraZeneca Survey: Healthcare Professionals Leading Source of Information on Companys Prescription Savings Programs
11. Diplomats 2008 Patient Satisfaction Survey Sets the Bar for Specialty Pharmacy Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
Breaking Biology Technology:
(Date:6/15/2016)... , June 15, 2016 ... report titled "Gesture Recognition Market by Application Market - Global Industry ... - 2024". According to the report, the  global gesture ... in 2015 and is estimated to grow at ... billion by 2024.  Increasing application of ...
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
Breaking Biology News(10 mins):